REST protects dopaminergic neurons from mitochondrial and α-synuclein oligomer pathology in an alpha synuclein overexpressing BAC-transgenic mouse model

REST protects dopaminergic neurons from mitochondrial and α-synuclein oligomer pathology in an alpha synuclein overexpressing BAC-transgenic mouse model

Alpha-synuclein pathology is associated with dopaminergic neuronal loss in the substantia nigra (SN) of Parkinson's patients. Working across human and mouse models, we investigated mechanisms by which the accumulation of soluble α-synuclein oligomers leads to neurodegeneration. Bioche...

Полное описание

Библиографические подробности
Главные авторы:	Ryan, BJ, Bengoa-Vergniory, N, Williamson, M, Kirkiz, E, Roberts, R, Corda, G, Sloan, M, Saqlain, S, Cherubini, M, Poppinga, J, Bogtofte, H, Cioroch, M, Hester, S, Wade-Martins, R
Формат:	Journal article
Язык:	English
Опубликовано:	Society for Neuroscience 2021

Схожие документы

Alpha-synuclein oligomers: a new hope.
по: Bengoa-Vergniory, N, и др.
Опубликовано: (2017)

Alpha-synuclein proximity ligation assay (AS-PLA) in brain sections to probe for alpha-synuclein oligomers
по: Roberts, RF, и др.
Опубликовано: (2019)

Targeting alpha-synuclein as a therapy for Parkinson’s disease
по: Fields, CR, и др.
Опубликовано: (2019)

Targeting Alpha-Synuclein as a Therapy for Parkinson’s Disease
по: Carroll Rutherford Fields, и др.
Опубликовано: (2019-12-01)

Region-specific deficits in dopamine, but not norepinephrine, signaling in a novel A30P α-synuclein BAC transgenic mouse.
по: Taylor, T, и др.
Опубликовано: (2014)

Loss of microRNA-7 regulation leads to α-synuclein accumulation and dopaminergic neuronal loss in vivo
по: McMillan, K, и др.
Опубликовано: (2017)

CO-CULTURE OF Α-SYNUCLEIN-TREATED IPSC-DERIVED DOPAMINERGIC NEURONS AND MICROGLIA AS AN IN VITRO MODEL OF PARKINSON’S DISEASE
по: Patricia Villegas-Zafra, и др.
Опубликовано: (2023-10-01)

Region-specific deficits in dopamine, but not norepinephrine, signaling in a novel A30P α-synuclein BAC transgenic mouse
по: Tonya N. Taylor, и др.
Опубликовано: (2014-02-01)

Mutation of Tyrosine Sites in the Human Alpha-Synuclein Gene Induces Neurotoxicity in Transgenic Mice with Soluble Alpha-Synuclein Oligomer Formation
по: Louise Berkhoudt Lassen, и др.
Опубликовано: (2022-11-01)

Lighting Up Alpha-synuclein Oligomers
по: Franziska Richter
Опубликовано: (2018-03-01)

TDP-43 Potentiates Alpha-synuclein Toxicity to Dopaminergic Neurons in Transgenic Mice
по: Tian Tian, Cao Huang, Jianbin Tong, Ming Yang, Hongxia Zhou, Xu-Gang Xia
Опубликовано: (2011-01-01)

Molecular and behavioural characterisation of novel alpha-synuclein BAC transgenic mouse models of Parkinson's disease
по: Janezic, S
Опубликовано: (2013)

α-Synuclein oligomers form by secondary nucleation
по: Catherine K. Xu, и др.
Опубликовано: (2024-08-01)

Stabilization of α-synuclein oligomers using formaldehyde.
по: Harm Ruesink, и др.
Опубликовано: (2019-01-01)

Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particles
по: Doucet, M, и др.
Опубликовано: (2017)

Exosomal cell-to-cell transmission of alpha synuclein oligomers
по: Danzer Karin M, и др.
Опубликовано: (2012-08-01)

Aggregated alpha-synuclein mediates dopaminergic neurotoxicity in vivo.
по: Periquet, M, и др.
Опубликовано: (2007)

Unconventional secretion of α-synuclein mediated by palmitoylated DNAJC5 oligomers
по: Shenjie Wu, и др.
Опубликовано: (2023-01-01)

α-Synuclein oligomers and fibrils: partners in crime in synucleinopathies
по: Alessandra Bigi, и др.
Опубликовано: (2023-01-01)

DJ-1 Acts as a Scavenger of α-Synuclein Oligomers and Restores Monomeric Glycated α-Synuclein
по: Tamr B. Atieh, и др.
Опубликовано: (2021-10-01)

Differential effects of immunotherapy with antibodies targeting α-synuclein oligomers and fibrils in a transgenic model of synucleinopathy
по: Omar El-Agnaf, и др.
Опубликовано: (2017-08-01)

Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particles.
по: Marika Doucet, и др.
Опубликовано: (2017-01-01)

Cellular α-synuclein pathology is associated with bioenergetic dysfunction in Parkinson's iPSC-derived dopamine neurons
по: Zambon, F, и др.
Опубликовано: (2019)

Alpha-synuclein oligomer-selective antibodies reduce intracellular accumulation and mitochondrial impairment in alpha-synuclein exposed astrocytes
по: Gabriel Gustafsson, и др.
Опубликовано: (2017-12-01)

The role of alpha-synuclein oligomers in Parkinson's disease pathophysiology and biology
по: Roberts, R
Опубликовано: (2015)

Characterization of α-synuclein oligomers formed in the presence of lipid vesicles
по: Anvesh K.R. Dasari, и др.
Опубликовано: (2024-07-01)

Structural characteristics and membrane interactions of tandem α-synuclein oligomers
по: Chunhua Dong, и др.
Опубликовано: (2018-04-01)

Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy
по: Julia E. Gerson, и др.
Опубликовано: (2018-03-01)

Temperature-dependent structural changes of Parkinson's alpha-synuclein reveal the role of pre-existing oligomers in alpha-synuclein fibrillization.
по: Winny Ariesandi, и др.
Опубликовано: (2013-01-01)

The Effect of Truncated Human α-Synuclein (1–120) on Dopaminergic Cells in a Transgenic Mouse Model of Parkinson's Disease
по: A. W. Michell, и др.
Опубликовано: (2007-05-01)

Lipidic folding pathway of α-Synuclein via a toxic oligomer
по: Vrinda Sant, и др.
Опубликовано: (2025-01-01)

Detrimental effects of soluble α-synuclein oligomers at excitatory glutamatergic synapses
по: Elena Ferrari, и др.
Опубликовано: (2023-03-01)

DOPAnization of tyrosine in α-synuclein by tyrosine hydroxylase leads to the formation of oligomers
по: Mingyue Jin, и др.
Опубликовано: (2022-11-01)

ELISA method to detect α-synuclein oligomers in cell and animal models.
по: Louise Berkhoudt Lassen, и др.
Опубликовано: (2018-01-01)

Transfer of host-derived alpha synuclein to grafted dopaminergic neurons in rat
по: Jeffrey H. Kordower, и др.
Опубликовано: (2011-09-01)

Nitrated alpha-synuclein immunity accelerates degeneration of nigral dopaminergic neurons.
по: Eric J Benner, и др.
Опубликовано: (2008-01-01)

The effect of truncated human alpha-synuclein (1-120) on dopaminergic cells in a transgenic mouse model of Parkinson's disease.
по: Michell, A, и др.
Опубликовано: (2007)

Upregulating β-hexosaminidase activity in rodents prevents α-synuclein lipid associations and protects dopaminergic neurons from α-synuclein-mediated neurotoxicity
по: Brekk, OR, и др.
Опубликовано: (2020)

α-Synuclein and mitochondrial bioenergetics regulate tetrahydrobiopterin levels in a human dopaminergic model of Parkinson disease.
по: Ryan, B, и др.
Опубликовано: (2014)

Carboxyl truncation of α-synuclein occurs early and is influenced by human APOE genotype in transgenic mouse models of α-synuclein pathogenesis
по: Grace M. Lloyd, и др.
Опубликовано: (2023-07-01)